SGLT2 inhibitors decrease cardiovascular death and heart failure hospitalizations in patients with heart failure: A systematic review and meta-analysis

BACKGROUND: Sodium–glucose cotransporter 2 (SGLT2) inhibitors reduce the composite of heart failure (HF) hospitalizations or cardiovascular mortality among patients with HF. However, the efficacy of SGLT2 inhibitors in secondary endpoints of randomized trials and in subgroups of HF patients is not w...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:EClinicalMedicine
Hlavní autoři: Cardoso, Rhanderson, Graffunder, Fabrissio P., Ternes, Caique M.P., Fernandes, Amanda, Rocha, Ana V., Fernandes, Gilson, Bhatt, Deepak L.
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier 2021
Témata:
Research Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8257984/
https://ncbi.nlm.nih.gov/pubmed/34308311
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eclinm.2021.100933
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky